Status:

COMPLETED

Efficacy and Safety of Activase (Ateplase) vs Placebo in Complicated Pleural Effusions (CPE)/Empyemas

Lead Sponsor:

Midwest Pulmonary and Critical Care

Collaborating Sponsors:

Genentech, Inc.

Conditions:

Pleural Effusion Associated With Pulmonary Infection

Bacterial Pleural Effusion Other Than Tuberculosis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to document the efficacy and safety of intrapleural instillation of Activase vs Placebo in the management of complicated pleural effusions and empyemas

Detailed Description

The current treatments available for complicated pleural effusions (CPE) include chest tube placement for drainage and IV antibiotics. If this fails and CPE occurs then in most patients thoracotomy is...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Diagnosed with complicated pleural effusions
  • Ability to provide written informed consent and comply with study assessments for the full duration of the study.
  • Age \> 18 years
  • Exclusion Criteria
  • Current use of oral anticoagulants (e.g., warfarin sodium) with an International Normalized Ratio (INR) \>5- Activated partial thromboplastin time (aPPT) \> 80, Platelet count \< 100,000/mm3;
  • Severe uncontrolled hypertension
  • Recognized hypersensitivity to Activase; or any component of its formulation; Traumatic pleural effusion
  • Pregnancy (positive pregnancy test)
  • In another study for this condition
  • Any other condition that the investigator believes would pose a significant hazard to the subject if the investigational therapy were initiated
  • Participation in another simultaneous medical investigation
  • Recent stroke
  • Intracranial hemorrhage
  • arteriovenous malformation or aneurysm
  • Intracranial neoplasm
  • Acute myocardial infarction
  • Acute pulmonary embolus

Exclusion

    Key Trial Info

    Start Date :

    April 1 2004

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    August 1 2009

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT00468104

    Start Date

    April 1 2004

    End Date

    August 1 2009

    Last Update

    April 30 2012

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Nebraska Methodist Hospital

    Omaha, Nebraska, United States, 68114